Bo Gao - Adjunct Assistant Professor - Hunter College | LinkedIn
Mount Sinai's Blood Test to Detect Antibodies to COVID-19 Receives Emergency Use Authorization From U.S. Food and Drug Administration - BroadcastMed
Mount Sinai Health System on Twitter: "Testing early for viral load may lead to better care for #patients with #COVID19. This study was led by Carlos Cordon-Cardo, MD, PhD: https://t.co/4VfUfsaOiJ #MountSinaiNews https://t.co/QMm5GwemUN" /
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
Events - Englander Institute for Precision Medicine
Carlos Cordon-Cardo, MD, PhD | System Wide Chairman of Pathology at the Icahn School of Medicine at Mount Sinai
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
Early Warning Score reduces incidence of serious events in general ward - Case study | Philips
Patient-centered care and technology: a powerful partnership | Philips
Health Technology Explained | Philips
El oncólogo Carlos Cordón-Cardó | Sociedad | EL PAÍS
Events - Englander Institute for Precision Medicine
Maturity Models: CIO's Guide to a Successful Enterprise Imaging Strategy - Blog | Philips
Ahmed Tanveer - Medical Doctor - Combined Military Hospital Rawalpindi | LinkedIn
Mount Sinai applies algorithms, AI to classify disease | Fierce Healthcare
Carlos Cordon-Cardo, MD, PhD – Mount Sinai | 5th International Prostate Cancer Symposium and World Congress of Urologic Oncology
About Dr. Cordon-Cardo | Carlos Cordon-Cardo, MD, PhD
Carlos Cordon-Cardo, MD, PhD - Physician's Channel - Mount Sinai New York
Carlos Cordon-Cardo, MD, PhD - Physician's Channel - Mount Sinai New York
COVID-19 pandemic (2019-21) - PLOS Collections
Hace dos siglos alguien de 40 años era una persona mayor, ahora con 70 es joven" | Salud | EL PAÍS
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Carlos Cordón-Cardo | Sociedad | EL PAÍS
COVID-19: Developing the Mount Sinai Antibody Test - Physician's Channel - Mount Sinai New York
